Blue Edge Capital LLC Sells 375 Shares of UnitedHealth Group Inc (UNH)

Blue Edge Capital LLC decreased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.0% during the third quarter, Holdings Channel reports. The fund owned 12,137 shares of the healthcare conglomerate’s stock after selling 375 shares during the period. UnitedHealth Group makes up 1.1% of Blue Edge Capital LLC’s holdings, making the stock its 25th largest position. Blue Edge Capital LLC’s holdings in UnitedHealth Group were worth $2,377,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares during the last quarter. BDO Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $121,000. Finally, Acrospire Investment Management LLC increased its holdings in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after acquiring an additional 400 shares during the last quarter. 86.24% of the stock is currently owned by institutional investors and hedge funds.

Shares of UnitedHealth Group Inc (NYSE:UNH) opened at $216.46 on Friday. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 52-week low of $156.49 and a 52-week high of $250.79. The company has a market capitalization of $209,760.00, a P/E ratio of 20.21, a price-to-earnings-growth ratio of 1.31 and a beta of 0.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter last year, the company earned $2.11 EPS. The company’s quarterly revenue was up 9.5% on a year-over-year basis. sell-side analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the sale, the director now owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michele J. Hooper sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total value of $2,377,600.00. Following the completion of the sale, the director now owns 37,284 shares of the company’s stock, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. Insiders sold a total of 53,853 shares of company stock valued at $12,358,508 in the last quarter. Corporate insiders own 0.89% of the company’s stock.

A number of research analysts have recently commented on the company. Oppenheimer increased their price objective on UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a report on Wednesday, October 18th. Cantor Fitzgerald reissued a “buy” rating and set a $208.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 17th. Morgan Stanley increased their price objective on UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. Citigroup raised their target price on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, Leerink Swann reaffirmed a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $243.22.

ILLEGAL ACTIVITY NOTICE: “Blue Edge Capital LLC Sells 375 Shares of UnitedHealth Group Inc (UNH)” was posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international trademark and copyright law. The original version of this piece of content can be read at https://www.com-unik.info/2018/02/09/blue-edge-capital-llc-sells-375-shares-of-unitedhealth-group-inc-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit